[go: up one dir, main page]

PL354484A1 - The use of flupirtine for the relief of pain associated with osteoarthritis in cats and dogs - Google Patents

The use of flupirtine for the relief of pain associated with osteoarthritis in cats and dogs

Info

Publication number
PL354484A1
PL354484A1 PL00354484A PL35448400A PL354484A1 PL 354484 A1 PL354484 A1 PL 354484A1 PL 00354484 A PL00354484 A PL 00354484A PL 35448400 A PL35448400 A PL 35448400A PL 354484 A1 PL354484 A1 PL 354484A1
Authority
PL
Poland
Prior art keywords
flupirtine
osteoarthritis
cats
dogs
relief
Prior art date
Application number
PL00354484A
Other languages
Polish (pl)
Inventor
Gabriele Endler
Holger Lehmann
Michael Lobisch
Istvan Szelenyi
Original Assignee
Awd Pharma Gmbh & Co.Kg
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Awd Pharma Gmbh & Co.Kg, Bayer Ag filed Critical Awd Pharma Gmbh & Co.Kg
Publication of PL354484A1 publication Critical patent/PL354484A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41521,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415Pyridoxine, i.e. Vitamin B6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51Thiamines, e.g. vitamin B1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/76Salicaceae (Willow family), e.g. poplar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL00354484A 1999-08-03 2000-07-29 The use of flupirtine for the relief of pain associated with osteoarthritis in cats and dogs PL354484A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14703399P 1999-08-03 1999-08-03
PCT/EP2000/007356 WO2001008682A2 (en) 1999-08-03 2000-07-29 Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats

Publications (1)

Publication Number Publication Date
PL354484A1 true PL354484A1 (en) 2004-01-26

Family

ID=22520069

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00354484A PL354484A1 (en) 1999-08-03 2000-07-29 The use of flupirtine for the relief of pain associated with osteoarthritis in cats and dogs

Country Status (20)

Country Link
EP (1) EP1242078A2 (en)
JP (1) JP2003530308A (en)
KR (1) KR20020040767A (en)
CN (1) CN1399550A (en)
AR (1) AR025030A1 (en)
AU (1) AU7271700A (en)
BR (1) BR0012942A (en)
CA (1) CA2314746A1 (en)
CO (1) CO5180569A1 (en)
CZ (1) CZ2002411A3 (en)
HR (1) HRP20020192A2 (en)
HU (1) HUP0301296A2 (en)
IL (1) IL147667A0 (en)
MX (1) MXPA02000997A (en)
NO (1) NO20020364L (en)
PL (1) PL354484A1 (en)
RU (1) RU2002105502A (en)
SK (1) SK1712002A3 (en)
WO (1) WO2001008682A2 (en)
ZA (1) ZA200200493B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10312346A1 (en) 2003-03-20 2004-09-30 Bayer Healthcare Ag Controlled release system
AU2004298288B2 (en) * 2003-12-16 2011-06-30 Relevare Aust. Pty Ltd Methods and compositions
CA2550023C (en) 2003-12-16 2011-04-12 Cnsbio Pty Ltd Treatment of neuropathic pain
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
DE102004001558A1 (en) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Medicinal products for topical application in animals
WO2006024018A2 (en) * 2004-08-24 2006-03-02 Neuromolecular Pharmaceuticals, Inc. Compositions for treating nociceptive pain
KR101067443B1 (en) 2009-06-23 2011-09-27 여오영 Topical injectable compositions for the treatment of hemorrhoids containing hydroxychloroquine
ITMI20120896A1 (en) * 2012-05-23 2013-11-24 Bongulielmi Reto CONDROITIN FOR USE IN MEDICINE
CN104523634A (en) * 2014-11-21 2015-04-22 哈尔滨圣吉药业股份有限公司 Flupirtine maleate sustained release tablet and preparation method thereof
RU2680244C1 (en) * 2017-12-28 2019-02-19 Общество С Ограниченной Ответственностью "Валента-Интеллект" Combination of flupirtine and cyclobenzaprine for treatment of pain syndromes
CN111371527B (en) 2018-12-25 2021-08-13 华为技术有限公司 A data transmission method and communication device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0189788B1 (en) * 1985-01-23 1989-09-13 ASTA Pharma Aktiengesellschaft Synergistic combination of flupirtin and non-steroidal anti-phlogistics
FI855016L (en) * 1985-06-28 1986-12-29 Degussa SYNERGISTIC COMBINATION AV FLUPIRTIN OCH 4-ACETAMIDO-PHENOL.
IN172468B (en) * 1990-07-14 1993-08-14 Asta Medica Ag
DE4236752A1 (en) * 1992-10-30 1994-05-05 Asta Medica Ag Combination preparation of flupirtine and morphine for the treatment of pain and for avoiding morphine addiction

Also Published As

Publication number Publication date
MXPA02000997A (en) 2003-10-14
CA2314746A1 (en) 2001-02-03
CN1399550A (en) 2003-02-26
NO20020364D0 (en) 2002-01-23
EP1242078A2 (en) 2002-09-25
IL147667A0 (en) 2002-08-14
HRP20020192A2 (en) 2004-02-29
HUP0301296A2 (en) 2003-08-28
BR0012942A (en) 2002-07-09
AR025030A1 (en) 2002-11-06
NO20020364L (en) 2002-01-23
ZA200200493B (en) 2003-04-30
WO2001008682A3 (en) 2002-07-18
JP2003530308A (en) 2003-10-14
KR20020040767A (en) 2002-05-30
RU2002105502A (en) 2004-03-20
WO2001008682A2 (en) 2001-02-08
SK1712002A3 (en) 2003-03-04
AU7271700A (en) 2001-02-19
CZ2002411A3 (en) 2003-03-12
CO5180569A1 (en) 2002-07-30

Similar Documents

Publication Publication Date Title
NO995389L (en) COX-2 selective carprofen for the treatment of pain and inflammation in dogs
PT1057751E (en) CARD CONTAINER TO CONTAIN AND PROVIDE WIRE
BR9710872A (en) M-todo for increased growth and yield in plants
EE200100373A (en) Benzoheterocycles and their use as MEK inhibitors
DK1141252T3 (en) Human delta-5 desaturase gene and uses thereof
BR9708882A (en) Triazolyl mercaptidas and their use as microbicides
ID28812A (en) ANTIMICROBIAL ENZIMA IN ANIMAL FEED
DE60019490D1 (en) Fuel conveyor and treatment device
PL354484A1 (en) The use of flupirtine for the relief of pain associated with osteoarthritis in cats and dogs
NO20022890L (en) New Heliobacter pylori-binding substances and their use
DE50011452D1 (en) POLYALKENALKOHOL-POLYALKOXYLATE AND THEIR USE IN FORCE AND LUBRICANTS
DE69919705D1 (en) DIARYLSELENIDE COMPOUNDS AND THEIR USE IN HUMAN OR ANIMAL MEDICINE AS IN COSMETOLOGY
DE69920224D1 (en) Urea derivatives for pain relief
ID25431A (en) APPLICATOR WITH HEALTH CARE
FI974353L (en) Directly applied solution for use against parasites in cattle and sheep
DE50016038D1 (en) USE OF NANOSCALANT ANTIMICROBIAL ACTIVE IN BODY DEODORANTIES
NO983953L (en) Azole compounds with antimycotic activity for use in human and veterinary medicine
NO306491B1 (en) Livestock farming and its use
DE69908592D1 (en) Continuous mixing and feeding device
LU90560B1 (en) Animal husbandry building - vents
NO20005727L (en) Polymer products and their use in oil
ES1044092Y (en) DEVICE COLLECTOR OF EXCREMENTS OF CATS AND THE LIKE.
NO974609L (en) Azole compounds with antimycotic activity for use in humans and animals
FI4002U1 (en) Breeding unit and arrangement in breeding unit
DE69909137D1 (en) Polyunsaturated fatty acid derivatives and their use in cancer treatment

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)